P852: NEOANTIGENS PREDICTED BY THE GNE NEOANTIGEN PIPELINE IN PATIENTS DIAGNOSED WITH DE NOVO MULTIPLE MYELOMA

• Y. Jiang,
• C. Henneges,
• S. Ruppert,
• P. Kimes,
• A. Amitai,
• A. Qamra,
• C. Dos Santos,
• J. N. Paulson,
• A. Bazeos

Affiliations

Y. Jiang

1 Product Development, Oncology, Roche Products Limited, Welwyn, United Kingdom

C. Henneges

2 Product Development Data Sciences

S. Ruppert

3 Oncology Biomarker Development, gRED, Genentech, Inc., South San Francisco, United States of America

P. Kimes

2 Product Development Data Sciences

A. Amitai

2 Product Development Data Sciences

A. Qamra

2 Product Development Data Sciences

C. Dos Santos

3 Oncology Biomarker Development, gRED, Genentech, Inc., South San Francisco, United States of America

J. N. Paulson

2 Product Development Data Sciences

A. Bazeos

1 Product Development, Oncology, Roche Products Limited, Welwyn, United Kingdom